Drug Profile
ICN 17261
Alternative Names: Levovirin; R 1270Latest Information Update: 18 Jul 2018
Price :
$50
*
At a glance
- Originator Valeant Pharmaceuticals International
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hepatitis C
Most Recent Events
- 13 Jul 2018 Valeant Pharmaceuticals International is now called Bausch Health Companies
- 04 Nov 2004 Data presented at the 55th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2004) have been added to the Viral Infections therapeutic trials section
- 14 Nov 2003 ICN Pharmaceuticals is now called Valeant Pharmaceuticals International